This list is an analysis based on recent market events. It's not an investment recommendation.
About
Vectura Group plc engages in the design, development, and supply of pharmaceutical products related to inhalation. Its products include flutiform, flutiform K-haler, Ultibro Breezhaler, Seebri Breezhaler, Enerzair Breezhaler, AirFluSal Forspiro, Airbufo Forspiro, Fluticasone Propionate and Salmeterol, Incruse Ellipta, Anoro Ellipta, Trelegy Ellipta, Relvar/Breo Ellipta, and Breelib. The company also provides formulation, process development and tech transfer, pharmaceutical analysis, product manufacturing, and device platforms services, as well as regulatory affairs, device vigilance, and pharmacovigilance services. In addition, it is developing VR315 (US), a generic Advair. Further, the company offers dry powder and pressurized metered dose inhalers, as well as vibrating mesh and jet nebulizers. Vectura Group plc was incorporated in 1997 and is based in Chippenham, the United Kingdom.
Show more...
CEO
Mr. William Downie
Employees
502
Country
UK
Listings
0 Comments
Share your thoughts
FAQ
What is Vectura stock price today?▼
The current price of VEC.LSE is GBX164.8 GBX — it has increased by +0% in the past 24 hours. Watch Vectura stock price performance more closely on the chart.
What is Vectura stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vectura stocks are traded under the ticker VEC.LSE.
Does Vectura pay dividends?▼
Yes, VEC.LSE dividends are paid en. The last dividend per share was 0.19 GBX. As of today, Dividend Yield (FWD)% is 11.53%.
How many employees does Vectura have?▼
As of April 04, 2026, the company has 502 employees.